18 November 2021 webinar The Good, the Bad and the Ugly; Organisation Change and the Impact of COVID19, Simon Chell (AstraZeneca), Tim Hardman (COVID19 Survey) At the start of 2020, most faced changes to the way we work with the…
Pharmaceutical projects are the main output of R&D in our industry and the key driver for growth and revenue, so it seems obvious that our project should be aligned with the strategy. I wonder if they are. What are the…
The first virtual session for PIPMG to restart our program of guidance and networking for life science project managers. This first one will aim to get people together for a short session and compare experiences of project management in the…
The outlook for the life sciences and pharmaceuticals sector in post Brexit Britain. The implications for project management 17 Jan 2020 Delivered in partnership with APM Speaker from the Head of the Policy Unit for Life Sciences at the CBI…